| dc.contributor.author | Hansen, Bettina E. | |
| dc.contributor.author | Cakaloglu, Yilmaz | |
| dc.contributor.author | Verhey, Elke | |
| dc.contributor.author | Janssen, Harry L. | |
| dc.contributor.author | Tabak, Fehmi | |
| dc.contributor.author | Rijckborst, Vincent | |
| dc.contributor.author | Zondervan, Pieter E. | |
| dc.contributor.author | Raptopoulou-Gigi, Maria P. | |
| dc.contributor.author | Akdogan, Meral | |
| dc.contributor.author | Simon, Krzysztof | |
| dc.contributor.author | Ferenci, Peter | |
| dc.date.accessioned | 2021-03-05T14:35:52Z | |
| dc.date.available | 2021-03-05T14:35:52Z | |
| dc.identifier.citation | Rijckborst V., Zondervan P. E. , Cakaloglu Y., Raptopoulou-Gigi M. P. , Tabak F., Akdogan M., Simon K., Ferenci P., Verhey E., Hansen B. E. , et al., "PEGINTERFERON TREATMENT REDUCES INTRAHEPATIC HBSAG AND HBCAG EXPRESSION IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: RELATION TO SERUM HBSAG DECLINE AND LONG-TERM RESPONSE", 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_b7ed0732-d0ff-4f4b-baa9-63ef33217ed7 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/122385 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.title | PEGINTERFERON TREATMENT REDUCES INTRAHEPATIC HBSAG AND HBCAG EXPRESSION IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: RELATION TO SERUM HBSAG DECLINE AND LONG-TERM RESPONSE | |
| dc.type | Bildiri | |
| dc.contributor.department | Erasmus University Rotterdam , , | |
| dc.identifier.volume | 54 | |
| dc.contributor.firstauthorID | 138764 | |
